PRTN3 and rheumatoid arthritis: Two previous studies reported higher levels of IgG-EBNA1 antibodies in patients with RA (30, 31) whereas three other studies did not (32–34), while a large Swedish study reported a lower level, particularly in ACPA-positive RA, and with no impact of RF (35).